Acer Therapeutics Inc (ACER) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acer Therapeutics Inc   (ACER)


Acer Therapeutics Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acer Therapeutics Inc's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Acer Therapeutics Inc 's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM - - - - -58.75 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -48 -29 -22 -7 -5
Return On Investment (TTM) - - - - -
ACER's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -40.24 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -48 -39 -33 -26 -21

ACER Company Profile >> Back to ACER Roi Comparisons >> See Annual ACER Return On Investment



Return On Investment ACER's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Acer Therapeutics Inc's III. Quarter Investments $ -48 Millions ACER's Balance sheet
Acer Therapeutics Inc's III. Quarter Income $ -15 Millions Quarterly ACER's Income Statement
ACER's Income by Division See ACER's Income by Division


ACER Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -7 7 8 19 45
Y / Y Investment Growth - -14 % -55.55 % -58.53 % 101.86 %
Net Income in Millions -26 -15 -23 -29 -21
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -215.11 % -275.37 % -157.34 % -47.2 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ACER's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ACER's Competitors
Subscribers only: Roi for Acer Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for ACER's Customers

Other Ratios
ACER's Roa ACER's Inventory Turnover Ratio ACER's Growth Rates ACER's Dividend Statistics
ACER's Profitability Ratios ACER's Asset Turnover Ratio ACER's Dividend Growth
ACER's Roe ACER's Valuation Ratios ACER's Financial Strength Ratios ACER's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Ir med Inc   300.96 %
Tff Pharmaceuticals Inc  241.72 %
Therapeuticsmd Inc   179.97 %
Inhibitor Therapeutics Inc   100.93 %
Glucotrack Inc   88.82 %
Scynexis Inc   79.06 %
Biomx Inc  76.77 %
Ladrx Corporation  74.45 %
Molecular Templates Inc   73.94 %
Avalo Therapeutics Inc   67.67 %
Opus Genetics Inc   65.54 %
Dariohealth Corp   57.65 %
Cv Sciences Inc   51.59 %
Elite Pharmaceuticals Inc   47.02 %
Gyre Therapeutics Inc   45.47 %
Star Equity Holdings Inc   44.42 %
Idexx Laboratories Inc  43.85 %
Entera Bio Ltd   41.70 %
Zymeworks Inc   39.50 %
Medpace Holdings Inc   38.76 %
Lite Strategy Inc   38.41 %
Enzo Biochem Inc  38.07 %
Northview Acquisition Corp  37.67 %

Date modified: 2026-08-29T17:21:34+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.